Baudax Bio, Inc. Contracts & Agreements

Amendment No. 7 to Credit Agreement, dated as of August 31, 2023, by and among Baudax Bio, Baudax Bio N.A. LLC, Baudax Bio Limited and TeraImmune, LLC, the lenders party thereto... (Filed With SEC on September 5, 2023)

Purchase Agreement, dated August 23, 2023, between Baudax Bio, Inc. and Alumni Capital LP (Filed With SEC on August 25, 2023)

Form of Securities Purchase Agreement (Filed With SEC on August 21, 2023)

Form of Series A-7 Warrant (Filed With SEC on August 21, 2023)

Form of Series E Pre-funded Warrant (Filed With SEC on August 21, 2023)

Biological Materials License Agreement, dated August 26, 2019, by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute and... (Filed With SEC on August 16, 2023)

Exclusive License Agreement, dated August 5, 2019, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc (Filed With SEC on August 16, 2023)

Exclusive License Agreement, dated November 11, 2020, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc (Filed With SEC on August 16, 2023)

Exclusive Patent License Agreement, dated as of June 18, 2020, by and between the U.S. Department of Health and Human Services, as represented by the National Institute of Allergy... (Filed With SEC on August 16, 2023)

Amendment No. 1 to Forbearance Agreement and Amendment No. 6 to Credit Agreement, dated as of July 30, 2023, by and among Baudax Bio, Baudax Bio N.A. LLC, Baudax Bio Limited and... (Filed With SEC on July 31, 2023)

Forbearance Agreement, dated as of June 29, 2023, by and among Baudax Bio, Inc, Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lender... (Filed With SEC on July 5, 2023)

Agreement and Plan of Merger, dated June 29, 2023, by and among Baudax Bio, Inc., Bounce Merger Sub I, Inc., Bounce Merger Sub II, LLC and TeraImmune, Inc (Filed With SEC on July 5, 2023)

Employment Agreement, by and between Baudax Bio, Inc. and Jillian Dilmore, dated May 10, 2023 (Filed With SEC on May 11, 2023)

Form of Securities Purchase Agreement, by and between Baudax Bio, Inc. and the purchasers party thereto (Filed With SEC on April 26, 2023)

Form of Placement Agent Warrant (Filed With SEC on April 26, 2023)

Form of Series D Pre-Funded Warrant (Filed With SEC on April 26, 2023)

Form of Series A-5 Warrant (Filed With SEC on April 26, 2023)

Asset Transfer Agreement among Alkermes Pharma Ireland Limited and Baudax Bio, Inc., dated as of March 29, 2023 (Filed With SEC on April 4, 2023)

Registration Rights Agreement between the Baudax Bio, Inc. and MAM Eagle Lender, LLC, dated March 29, 2023 (Filed With SEC on March 31, 2023)

Amendment No. 5 to Credit Agreement, dated March 29, 2023, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the... (Filed With SEC on March 31, 2023)

Common Stock Purchase Warrant, dated March 29, 2023, in favor of MAM Eagle Lender, LLC (Filed With SEC on March 31, 2023)

Form of Warrant Amendment Agreement (Filed With SEC on December 5, 2022)

Amendment No. 3 to Credit Agreement, dated December 1, 2022, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and... (Filed With SEC on December 1, 2022)

Form of Securities Purchase Agreement, by and between Baudax Bio, Inc. and the purchasers party thereto (Filed With SEC on November 28, 2022)

Form of Placement Agent Warrant (Filed With SEC on November 28, 2022)

Form of Series C Pre-Funded Warrant (Filed With SEC on November 28, 2022)

Form of Series A-3 Warrant (Filed With SEC on November 28, 2022)

Amendment No. 2 to Credit Agreement, dated October 24, 2022, by and among Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and... (Filed With SEC on October 28, 2022)

Form of Warrant Amendment Agreement (Filed With SEC on August 25, 2022)

Form of Securities Purchase Agreement, by and between Baudax Bio, Inc. and the purchasers party thereto (Filed With SEC on August 17, 2022)

Form of Placement Agent Warrant (Filed With SEC on August 17, 2022)

Form of Series B Pre-Funded Warrant (Filed With SEC on August 17, 2022)

Form of Series A-2 Warrant (Filed With SEC on August 17, 2022)

Form of Series A-1 Warrant (Filed With SEC on August 17, 2022)

Amendment No. 1 and Waiver to Credit Agreement, dated August 1, 2022, by and Baudax Bio, Inc., Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and... (Filed With SEC on August 3, 2022)

Form of Securities Purchase Agreement (Filed With SEC on May 18, 2022)

Form of Placement Agent Warrant (Filed With SEC on May 18, 2022)

Form of Warrant (Filed With SEC on May 18, 2022)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2022)

Form of Warrant, issued June 1, 2021 (Filed With SEC on March 16, 2022)

Form of Underwriter Warrant (Filed With SEC on March 1, 2022)

Form of Pre-Funded Warrant (Filed With SEC on March 1, 2022)

Form of Investor Warrant (Filed With SEC on March 1, 2022)

Underwriting Agreement, dated February 24, 2022, by and between Baudax Bio, Inc. and H.C. Wainwright and Co., LLC (Filed With SEC on March 1, 2022)

Form of Warrant (Filed With SEC on December 28, 2021)

Form of Securities Purchase Agreement (Filed With SEC on December 28, 2021)

Form of Placement Agent Warrant (Filed With SEC on December 28, 2021)

Form of Securities Purchase Agreement (Filed With SEC on June 1, 2021)

Form of Placement Agent Warrant (Filed With SEC on June 1, 2021)

Form of Warrant (Filed With SEC on June 1, 2021)

Employment Agreement between Baudax Bio, Inc. and Richard S. Casten, dated March 8, 2021 (Filed With SEC on March 11, 2021)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 16, 2021)

Form of Stock Option Award Agreement (Filed With SEC on February 16, 2021)

Form of Restricted Stock Unit Award Agreement (Filed With SEC on February 16, 2021)

Form of Performance-Based Restricted Stock Unit Award Agreement (Filed With SEC on February 16, 2021)

Form of Award Agreement for Option Inducement Award (Filed With SEC on February 16, 2021)

Form of Award Agreement for Restricted Stock Unit Inducement Award (Filed With SEC on February 16, 2021)

Form of Securities Purchase Agreement (Filed With SEC on February 9, 2021)

Form of Placement Agent Warrant (Filed With SEC on February 9, 2021)

Form of Letter Agreement (Filed With SEC on January 22, 2021)

Form of Placement Agent Warrant (Filed With SEC on January 22, 2021)

Form of Warrant (Filed With SEC on January 22, 2021)

Form of Securities Purchase Agreement (Filed With SEC on December 18, 2020)

Form of Placement Agent Warrant (Filed With SEC on December 18, 2020)

Form of Series B Warrant (Filed With SEC on December 18, 2020)

Form of Series A Warrant (Filed With SEC on December 18, 2020)

Form of Series A Warrant (Filed With SEC on November 24, 2020)

Form of Series B Warrant (Filed With SEC on November 24, 2020)

Form of Securities Purchase Agreement (Filed With SEC on November 24, 2020)

Form of Placement Agent Warrant (Filed With SEC on November 24, 2020)

Form of Warrant Exchange Agreement (Filed With SEC on October 20, 2020)

Third Amendment to License Agreement, dated August 17, 2020, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC and Baudax Bio, Inc (Filed With SEC on August 21, 2020)

Third Amendment to the Purchase and Sale Agreement, dated August 17, 2020 by and among Alkermes Pharma Ireland Limited, Daravita Limited, Alkermes US Holdings, Inc. and Baudax... (Filed With SEC on August 21, 2020)

Intellectual Property Security Agreement, dated as of May 29, 2020, by and among the Company, Baudax Bio N.A. LLC, Baudax Bio Limited and Wilmington Trust, National Association (Filed With SEC on June 2, 2020)

Security Agreement, dated as of May 29, 2020, by and among the Company, Baudax Bio N.A. LLC, Baudax Bio Limited and Wilmington Trust, National Association (Filed With SEC on June 2, 2020)

Credit Agreement, dated as of May 29, 2020, among the Company, the lenders party thereto and Wilmington Trust, National Association (Filed With SEC on June 2, 2020)

Common Stock Purchase Warrant, dated May 29, 2020, in favor of MAM Eagle Lender, LLC (Filed With SEC on June 2, 2020)

Note dated May 8, 2020, between Baudax Bio, Inc. and PNC Bank, National Association (Filed With SEC on May 13, 2020)

Description of Securities (Filed With SEC on May 8, 2020)

Form of Series B Warrant (Filed With SEC on March 24, 2020)

Underwriting Agreement, dated March 24, 2020, by and between Baudax Bio, Inc. and JMP Securities LLC, as representative of the several underwriters named therein (Filed With SEC on March 24, 2020)

Form of Series A Warrant (Filed With SEC on March 24, 2020)

Sales Agreement, dated February 13, 2020, by and between Baudax Bio, Inc. and JMP Securities LLC (Filed With SEC on February 13, 2020)

Amendment to Employee Matters Agreement, dated February 12, 2020, by and between Recro Pharma, Inc. and Baudax Bio, Inc. . 10.29 Sales Agreement, dated February 13, 2020, by and... (Filed With SEC on February 13, 2020)

Employment Agreement, dated February 12, 2020, between Baudax Bio, Inc. and Ryan D. Lake (Filed With SEC on February 13, 2020)

Employment Agreement, dated February 12, 2020, between Baudax Bio, Inc. and Gerri Henwood (Filed With SEC on February 13, 2020)

Amendment to License Agreement, dated October 21, 2019, by and between Cornell University and Recro Pharma, Inc (Filed With SEC on February 13, 2020)

Separation Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc (Filed With SEC on November 26, 2019)

Assignment, Assumption and Bifurcation Agreement, dated November 20, 2019, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC, Recro Pharma, Inc. and Baudax Bio,... (Filed With SEC on November 26, 2019)

Baudax Bio, Inc. 2019 Equity Incentive Plan (Filed With SEC on November 26, 2019)

Employee Matters Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc (Filed With SEC on November 26, 2019)

Tax Matters Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc (Filed With SEC on November 26, 2019)

Transition Services Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc (Filed With SEC on November 26, 2019)

Category

Industry

Companies

Contracts

Baudax Bio, Inc. Contracts & Agreements